Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Defence Therapeutics Inc (DTC.CN)

Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Therapeutics Announces AGM Results and Provides Corporate Updates Newsfile - Wed Dec 10, 3:36PM CST

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs Newsfile - Thu Dec 4, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Announces Convertible Debenture Conversion Newsfile - Fri Nov 21, 5:12PM CST

Montreal, Quebec--(Newsfile Corp. - November 21, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology Newsfile - Wed Nov 19, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - November 19, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models Newsfile - Tue Nov 4, 2:30AM CST

Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025 Newsfile - Thu Oct 23, 2:22AM CDT

Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Upcoming Meeting Dates - October 13, 2025 Newsfile - Sun Oct 12, 11:08PM CDT

Toronto, Ontario--(Newsfile Corp. - October 13, 2025) -  The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

NOBL.VN : 0.150 (+7.14%)
SKP.VN : 0.140 (+3.70%)
HTRC.CN : 0.1750 (-5.41%)
CAD.VN : 2.210 (+6.76%)
OTEX.TO : 46.06 (-0.17%)
DGX.VN : 4.070 (+20.77%)
LCX.VN : 0.560 (unch)
ROK.VN : 0.225 (unch)
HCC.VN : 0.010 (unch)
JJ.VN : 0.100 (unch)
ACS.VN : 0.095 (-42.42%)
KLM.VN : 0.005 (unch)
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025 Newsfile - Mon Oct 6, 2:18AM CDT

Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations Newsfile - Thu Oct 2, 2:18AM CDT

Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)

Barchart Exclusives

The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside Barchart - Sat Dec 20, 11:00AM CST
These biotech bets are only for investors who can stomach volatility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot